DaVita Inc.

DVA Healthcare Medical Care Facilities

DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024. In the quarter to June 2026, revenue grew 5.17%, EPS grew 56.5%, free cash flow grew 49.4% and total debt rose 4.40%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

187.31 1.85 −0.98%
Market cap
$12.1B
P/E
15.0×
Fwd P/E
13.1×
Dividend yield
—
F-score
6/9
Altman Z
1.49
Beneish M
−2.59
Dividend safety
n/a

DaVita Inc. (DVA) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, DaVita Inc. (DVA) trades at a P/S ratio of 0.9×. Over the past ten years it has ranged from 0.5× (November 2022) to 1.8× (December 2017); the current reading is higher than 33% of that period. That is in line with the Medical Care Facilities industry median of 0.9× and below the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 0.6× (37.68%)
FY2024 1.0× 24.07%
FY2023 0.8× 33.37%
FY2022 0.6× (41.82%)
FY2021 1.0× (15.38%)
FY2020 1.2× 20.65%
FY2019 1.0× 30.96%
FY2018 0.8× (38.74%)
FY2017 1.3× 2.63%
FY2016 1.2× (17.15%)

Quarterly newest first

Period P/S ratio Change
Jun 2026 1.0× 37.43%
Mar 2026 0.7× 21.11%
Dec 2025 0.6× (14.05%)
Sep 2025 0.7× (12.52%)
42 more quarters

Against its own ten years

Low 0.5× High 1.8×
Ten-year median 1.0×
Current reading's percentile 36

P/S ratio against peers

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on DVA